Senhwa Biosciences, Inc. @senhwabio
Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses. senhwabio.com TAIPEI and San Diego, CA Joined July 2014-
Tweets23
-
Followers47
-
Following2
-
Likes4
Trends for United States
1,89 Mn posts
246 B posts
100 B posts
19,6 B posts
98,1 B posts
9.900 posts
17,6 B posts
83,9 B posts
71,6 B posts
45,2 B posts
71,5 B posts
37 B posts
2.996 posts
43,7 B posts
4.256 posts
64,2 B posts
13,5 B posts
49,8 B posts